Cannbit Pharmaceuticals Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cannbit Pharmaceuticals Ltd with three other
pharmaceutical manufacturers in Middle East:
sales of 3.77 million Israel Shekels [US$1.04 million]
Rosetta Genomics Ltd. (USA)
(1.46 million Israel Shekels [US$400,975.09 ]
Sabaa International Co For Pharmaceutical And Chemical Industries
based in Egypt
(15.32 million Egyptian Pounds [US$870,701.44 ]
Sales fell dramatically in 2013:
During the year ended December of 2013, sales at
Cannbit Pharmaceuticals Ltd were 2.60 million Israel Shekels (US$713.77 thousand).
decrease of 72.2%
versus 2012, when the company's sales were 9.35 million Israel Shekels.